Source: International Congress 2018 – Cardiovascular morbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ghosh (Leicester, United Kingdom), M. Bridge (Leicester, United Kingdom), N. Shahid (Leicester, United Kingdom), A. Jones (Leicester, United Kingdom), N. O'Kelly (Lincoln, United Kingdom). Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease.. 739

Member's Comments

No comment yet.

Related content which might interest you: One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Evaluation of the clinical efficacy of the fluticasone-salmeterol fixed dose combination (FDC) in Greek patients with Chronic Obstructive Pulmonary Disease-AEOLOS study Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand? Source: International Congress 2018 – COPD management Year: 2018 Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision Source: Eur Respir J, 56 (1) 2000627; 10.1183/13993003.00627-2020 Year: 2020 Home management of severe Chronic Obstructive Pulmonary Disease (COPD): results from a randomized controlled study in Italy Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir Rev 2009; 18: 133 Year: 2009 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Repeatability of multiple breath washout measurements in stable Chronic Obstructive Pulmonary Disease. Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD). Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Effects of a self-management program in exacerbated Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Airway infection in COPD Year: 2019 Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients. Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Airway diseases and blood cells Year: 2019